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1. Introduct;on 
Evidence has been accumulating which suggests that 
the binding of EF G and GTP takes place at or near 
the A site of the ribosome which accepts the complex 
of EF Tu, aminoacyl-tRNA and GTP. Thus, the com- 
plex of GMPPCP with EF G as well as fusidic acid and 
GDP with EF G has been found to inhibit the binding 
of aminoacyl-tRNA effectively at the A site [l-4] . 
These results suggested that the site for EF G and 
GMPPCP binding may be identical to or overlap with 
that for EF G, GDP, and fusidic acid. On the other 
hand, recent evidence suggests that these sites are 
similar but not identical to each other [5]. In this 
communication, we report that the puromycin reaction 
of N-acetyl[’ 4 C] phenylalanyl-t RNA bound nonenzy- 
matically at the D site is significantly inhibited by 
the presence of EF G and GMPPCP, while it is insensi- 
tive to the presence of EF G, fusidic acid and GTP, 
indicating that these two sites are distinctly different 
in terms of its effect on the peptidyl transferase ac- 
tivity. 
2. Materials and methods 
2.1. Materials 
E. coli B (early log) and E. coli Q13 (middle log) 
were purchased from the Grain Processing Company 
and General Biochemicals, respectively. Ribosomes 
from E. coli Q13 and EF G from E. coli B were 
prepared as described previously [6]. .5’-Guanylyl- 
methylene diphosphonate (GMPPCP) was obtained 
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from Miles Laboratories. Fusidic acid (Na salt) (Batch 
# 14) was a gift from E. R. Squibb and Sons Co. 
through the courtesy of Dr. A. Laskin. The specific 
activities of [“Cl phenylalanine and [“HI methionine 
were 455 Ci/mole and 3270 Ci/mole, respectively. 
Preparation of [I4 C] phenylalanyl-tRNA [7] , N- 
acetyl [‘4C]phenylanyl-tRNA 181 and formyl [3 HI- 
methionyl-tRNA [9] were obtained as described 
previously. The counting efficiencies of I4 C and 3 H 
were lo6 cpm/pc and 4.9 X 10’ cpm/gc, respect- 
ively. 
2.2. Preparation of the various ribosomal complexes 
The mixture (0.5 ml) for the formation of the com- 
plex having N-acetyl[’ 4 C] phenylalanyl-tRNA 
nonenzymatically bound at the D site contained 50 
mM Tris-HCl (pH 7.2), 50 mM NH4C1, 6 mM Mg 
acetate, 2.64 mg of ribosomes, 100 pg of polyuridic 
acid (poly U), and 550 pg of tRNA containing 2.5 
X 10’ cpm of N-acetyl[’ 4 C] phenylalanyl-t RNA 
The mixture was incubated for 20 min at 30°C. The 
complex was isolated on a Sephadex G-l 00 column 
[lOI. 
The procedure for the formation of the complex 
having non-enzymatically bound [’ 4 C] phenylalanyl- 
tRNA at the D site was similar to that for N-acetyl- 
[ 1 4 C] phenylalanyl-tRNA except that it (0.5 ml) con- 
tained 1 mM dithiothreitol (DTT), 140 pg of poly 
U, 2.46 mg of tRNA containing 7.5 X 10’ cpm of 
[’ 4 C] phenylalanyl-tRNA and 3.7 mg of ribosomes. 
The complex thus formed was isolated by the sucrose 
density gradient method [6]. 
The procedure for the preparation of the ribosomal 
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complex having N-acetyl [’ 4 C] phenylalanyl-tRNA at 
the D site which was translocated from the A site by 
the action of EF G and GTP was as follows. In the 
first step, the ribosomal complex having tRNAphe 
and N-acetyl[’ 4 C] phenylalanyl-tRNA at the D and 
the A site respectively, was prepared as described 
previously [ lo] . The reaction mixture (1 ml) con- 
tained 50 mM Tris-HCl (pH 7.2), 50 mM NH4Cl, 
14 mM Mg acetate, 1 mM DTT, 805 pg of ribosomes, 
2 mg of tRNA containg 9 X lo5 cpm of N-acetyl- 
[‘4C]phenylalanyl-tRNA and 200 pg of poly U. The 
mixture was incubated for 15 min at 30°C. The 
complex formed was then mixed with 0.5 mM puromy- 
tin and further incubated for 25 min at 30°C to 
convert N-acetyl[’ “C] phenylalanyl-tRNA at the D 
site to tRNAphe. The complex formed was isolated 
by the sucrose gradient method. In the second step, 
the A-site bound N-acetyl [‘“Cl phenylalanyl-tRNA 
was translocated to the D site. The mixture (0.6 ml) 
for the translocation reaction contained 50 mM Tris- 
HCl (pH 7.2), 50 mM NH4C1, 13 mM Mg acetate, 
1 mM DTT, 0.1 mM GTP, 23.6 pg of EF G and 4.65 
A zbO,munits of the ribosomal complex containing 
1.22 X 1 O4 cpm of N-acetyl [14 C] phenylalanyl-tRNA 
obtained as described above. The mixture was incubat- 
ed for 30 min at 37°C to complete the translocation 
reaction. This complex thus obtained was used for 
the puromycin reaction of the bound N-acetyl [14 Cl- 
phenylalanyl-tRNA. 
The mixture (0.5 ml) for the formation of the com- 
plex having non enzymatically bound N-acetyl [I4 ] - 
phenylalanyl-tRNA both at the A and the D site 
contained 50 mM Tris-HCl (PM 7.2), 50 mM NH4C1, 
13 mM Mg acetate, 2.64 mg of ribosomes, 100 pg of 
poly U and 1.1 mg of tRNA containing 5 X 10’ cpm 
of N-acetyl [ I4 C] phenylalanyl-tRNA. The incubation 
was carried out for 20 min at 30°C and the complex 
thus formed was isolated on a Sephadex G-100 column. 
The mixture (0.5 1 ml) for the formation of the 
initiation complex with phage MS2 RNA contained 
50 mM Tris-HCl (pH 7.2), 60 mM NH4C1, 10 mM 
Mg acetate, 1 mM DTT, 0.2 mM GTP, 625 pg of crude 
initiation factors (ribosomal wash) [ 111, 500 pg of 
MS2RNA [ 1 I], 4.6 mg of ribosomes and 2.4 mg of 
tRNA containing 1.8 X 10’ cpm of formyl[3H]- 
methionyl-tRNA. The incubation was carried out for 
20 min at 37°C and the initiation complex formed 
was isolated by the sucrose density gradient. 
3. Results 
3.1. Inhibition of peptide bond formation by EF G 
and GMPPCP 
It has been found that in the presence of 6 mM 
Mg”N-acetylphenylalanyl-tRNA as well as phenylal- 
anyl-tRNA bind almost exclusively to the D site [ 12 1. 
In the experiment shown in fig. 1, the complex of 
N-ace tyl[ l4 C] phenylalanyl-tRNA with ribosome and 
poly U was prepared in this fashion, and the puromycin 
reaction with the bound iV-acetyl [’ 4 C] phenylalanyl- 
tRNA was studied in the presence of GMPPCP and 
various amounts of EF G. As indicated in this figure, 
the progressive inhibitory effect of GMPPCP and EF G 
was observed as the amount of EF G in the reaction 
mixture was increased. It should be noted in this 
figure that in a similar experiment fusidic acid, GTP 
and EF G did not exert any significant effect on the 
N-acetyl[14C]phenylalanyl puromycin formation. The 
inhibitory effect of EF G is dependent on the presence 
- 
EF G (pg) 
Fig. 1. Effect of various amounts of EF G on; the puromycin 
reaction with the D site nonenzymatically bound N-acetyl- 
[ ’ 'C] phenylalanyl-tRNA. The mixture (0.1 ml) for the 
puromycin reaction contained 50 mM Tris-HCI (pH 7.2), 
50 mM NH,Cl, 6 mM Mg acetate, 1 mM DTT, 0.6 mM 
puromycin and 1 A,,,,,m unit of the complex containing 
2.8 X lo3 cpm of N-acetyl[‘4C]phenylalanyl-tRNA ob- 
tained as described in ‘Materials and methods’. Where indicat- 
ed, none (o), 1 mM GMPPCP co), 1 mM fusidic acid and 0.1 
mM GTP (X), 0.1 mM GTP (A) and the indicated amounts 
of EF G were added. The mixture was incubated for 10 min 
at 30°C. 0.8 ml of 10 mM Tri-HCl (pH 7.8) and 2 ml of 
ethylacetate were added to this mixture and after shaking 
vigorously, 1.5 ml of the ethylacetate fraction were counted 
in 5 ml Bray’s solution [22]. 
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Fig. 2. Inhibitory effect of various amounts of GMPPCP on 
the puromycin reaction with the D site nonenzymatically 
bound N-acetyl[“‘C]phenylalanyl-tRNA. The procedure 
for the puromycin reaction was essentially the same as that 
of fig. 1. Where indicated, 11.7 rug of EF G (o) and the 
various amounts of CMPPCP were added. (0) No EF G was 
added. 
of GMPPCP and GTP did not substitute for GMPPCP 
for this effect. The maximum inhibition on the puro- 
mycin reaction was observed when approximately two 
molecules of EF G were present per one ribosomal 
complex. When the concentration of GMPPCP was 
varied, the inhibition was apparent at 10e4 M (fig. 
2). The Ki value for GMPPCP obtained from the 
competitive inhibitory effect on the release tRNA was 
6 X 10T4 M [ 131. Thus, the maximum effect of 
GMPPCP was obtained well below the Ki value of 
GMPPCP on translocation. It is noted in this figure 
also that the complete inhibition could not be ob- 
tained even with ten-fold higher concentration of 
GMPPCP. A similar inhibitory effect of EF G and 
GMPPCP on peptide bond formation was observed 
with the D site bound phenylalanyl-tRNA (table 1). 
One can therefore conclude that the blocking of free 
amino group is not necessary for the inhibitory effect 
of GMPPCP and EF G on the puromycin reaction. 
It has been found previously that the presence of 
tRNA or N-acetyl phenylalanyl-tRNA at the A site 
may retard the rate of the puromycin reaction with 
the D site bound iV-acetyl[‘4C]phenylalanyl-tRNA 
[ 141. The hindrance due to the presence of N-acetyl- 
[“Cl phenylalanyl-tRNA at the A site was not observ- 
ed, however, on the final level of the puromycin 
derivative formed [ 141. Thus it is possible to react 
Table 1 
Inhibitory effect of EF G and GMPPCP on the puromycin 
reaction with the nonenzymatically bound 
[‘“Cl phenylalanyl-tRNA at the D site 
EF G GMPPCP [’ 4 Cl phenylalanyl, puromycin 
formed (cpm) 
300 
_ t 291 
f _ 289 
+ t 147 
The mixture (0.2 ml) for the puromycin reaction contained 
50 mM Tris-HCl (pH 7.2), 80 mM NH,Cl, 13 mM Mg acetate, 
1 mM DTT, 0.5 mM puromycin and 2 A,,, nm units of the 
complex containing 1.8 X lo3 cpm of [i4C]phenylalanyll 
tRNA obtained as described in ‘Materials and methods’. 
Where indicated, 23.6 ~.rg of EF G and 0.2 mM GMPPCP 
were added. The incubation was carried out for 30 min at 
30°C 0.8 ml of 10 mM Tris-HCI (pH 7.8) and 2.5 ml of 
ethylacetate wereadded to the mixture, and after shaking 
vigorously, 2 ml of ethylacetate fraction were counted in 
10 ml of Bray’s solution. 
the D site bound N-acetyl[’ 4 C] phenylalanyl-tRNA 
with puromycin even in the presence of the other 
N-acetyl[’ 4 C] phenylalanyl-tRNA on the A site. It 
has also been reported that the presence of aminoacyl- 
tRNA at the A site may [ 151 or may not [4] inhibit 
the binding of EF G to the ribosomes. It was therefore 
of interest to examine the effect of EF G and GMPPCP 
on the puromycin reaction with the complex which 
has N-acetyl[’ 4 C] phenylalanyl-tRNA both at 
the A and the D sites. Such complexes can be prepared 
in the presence of 13 mM Mg” becauseN-acetyl[14C]- 
phenylalanyl-tRNA binds to both the A and D sites of 
the ribosomes in the absence of any added factors [ 121 
In the experiment shown in table 2, it is clear that 
EF G and GMPPCP exert an inhibitory effect on the D 
site bound N-acetyl [’ 4 C] phenylalanyl-tRNA even 
if the A site was occupied, suggesting that the 
presence of nonenzymatically bound N-acetyl[14C]- 
phenylalanyl-tRNA at the A site may not interfere 
with the binding of EF G and GMPPCP to the riboso- 
me. It is noted in this table that the puromycin reac- 
tion was more than doubled by the addition of EF G 
and GTP, indicating that the A site is occupied under 
the experimental conditions used. 
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Table 2 
Inhibitory effect of EF G and GMPPCP on the puromycin 
reaction with the complex havingN-acetyl[‘4C]- 
phenylalanyl-tRNA both at the A and the D site 
EF G 
olg) 
GMPPCP GTP N-acetyl[’ ‘C] phenylalanyl 
puromycin formed (cpm) 
_ + _ 992 
3.8 - _ 1093 
3.8 + _ 131 
19.0 - _ 1193 
19.0 + _ 693 
19.0 - + 2416 
The procedure for the puromycin was essentially the same 
as that of fig. 1 except that it contained 13 mM MR acetate 
and 1.24 A,,, nm units of the complex containing 5.6 X 
10~ cpm of N-acetyl[ 14C]phenylalanyl-tRNA obtained as 
described in ‘Materials and methods’. Where indicated, 0.2 
mM GMPPCP, 0.1 mM GTP, and the various amounts of 
EF G were added. The incubation was carried out for 15 min 
at 30°C. 
Table 3 
Reversal of the inhibitory effect of EF G and GMPPCP on the 
peptide bond formation by GDP 
GMPPCP 
(mM) 
GDP N-acetyl[ “‘Clphenyl- % inhibition 
(mM) alanyl puromycin 
formed (cpm) 
_ _ 1130 
0.2 _ 591 47 
_ 0.2 1041 
0.2 0.2 790 24 
_ 0.5 1172 
0.2 0.5 964 18 
The procedure for the puromycin reaction was essentially the 
same as that of fig. 1 except that it contained 14 pg of EF G 
and 1.17 A,,, nm units of the complex containing 2.9 X 1 O3 
cpm of N-acetyl[’ 4 C] phenylalanyl-t RNA obtained as des- 
cribed in ‘Materials and methods’. Where indicated, 0.2 mM 
GMPPCP and the various amounts of GDP were added. 
3.2. The reversal of the effect of Gh4PPCP by GDP 
It has been reported that the binding of EF G to 
ribosomes in the presence of GMPPCP is competitively 
inhibited by the increasing concentration of GDP [ 161 
It was therefore expected that the addition of GDP 
may release the inhibitory effect of GMPPCP on the 
puromycin reaction. The data in table 3 show that 
this is indeed the case. GMPPCP (0.2 mM) inhibited 
the puromycin reaction approximately 50% and this 
inhibitory effect was diminished by 50% in the 
presence of the equal concentration of GDP. Higher 
reduction of GMPPCP inhibitory effect was observed 
with a higher concentration of GDP, suggesting the 
competitive nature of GDP and GMPPCP. 
3.3. The effect of EF G and GMPPCP on N-blocked 
aminoacyl-tRNA which was placed on the D site 
by the initiation factors or EF G 
During polypeptide synthesis, under the physiologi- 
cal condition, the ribosome will go through a stage 
where it has peptidyl-tRNA on the D site and 
aminoacyl-tRNA at the A site. If EF G and GTP bind 
to the ribosome at this stage in a similar fashion to 
the binding of EF G and GMPPCP, one might expect 
this binding may interfere with the physiological 
process of the peptide bond formation. This would 
then result in retardation of peptide bond formation, 
because it will not take place until EF G is released 
from the ribosome. To examine this possibility, N- 
blocked aminoacyl-tRNA was placed on the D site 
by the physiological means and the puromycin reac- 
tion with this N-blocked aminoacyl-tRNA was car- 
ried out and the effect of EF G and GMPPCP was 
tested on this reaction. In this experiment, N-acetyl- 
[’ 4 C] phenylalanyl-tRNA, poly U, and ribosomal 
complex was prepared at 13 mM Mg2’ and puromycin 
was allowed to react with the complex, converting 
N-acetyl [I4 C] phenylalanyl-tRNA bound at the D 
site to tRNAphe. To this complex were added EF G 
and GTP to translocate N-acetyl[’ 4 C] phenylalanyl- 
tRNA at the A site to the D site and to release the 
D site bound tRNAphe. Thus the complex obtained 
here represents one which contains N-acetyl [14 Cl- 
phenylalanyl-tRNA at the D site by the action of EF 
G and GTP. The puromycin reaction with the bound 
N-acetyl [I4 C] phenylalanyl-tRNA on this complex 
was examined. As shown in table 4, no appreciable 
effect of EF G and GMPPCP was observed on the 
puromycin reaction of N-acetyl[’ 4 C] phenylalanyl- 
tRNA placed on the D site by the action of EF G. 
That this was not due to the possible presence of 
residual GDP in the system was shown by the observa- 
tion that even ten fold higher concentration of 
GMPPCP did not cause appreciable decrease of pep- 
tide bond formation reaction. 
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Table 4 
Effect of EF G and GMPPCP on the puromycin reaction with 
the D site bound N-acetyl[’ “C] phenylalanyl-tRNA which 
was translocated from the A site by the action of EF G 
EFG GMPPCP N-acetyl[ “C]phenylalanyl pu,umycin 
formed (cpm) 
+ 1878 
_ t 1784 
t t 1668 
The mixture (0.2 ml) for the puromycin reaction contained 
170 t.d of the mixture, which contained the complex having 
N-acetyl[ “C]plienylalanyl-tRNA at the D site, obtained as 
described in ‘Materials and methods’. Where indicated, 11.8 
pg of EF G and 1 mM GMPPCP were added. The incubation 
was carried out for 10 min at 30°C. The rest of the procedure 
was essentially the same as that of table 1. 
Table 5 
Effect of EF G and GMPPCP on the puromycin reaction with 
the formyl[ aH] methionyl- tRNA of the initiation complex 
EF G GMPPCP Formyl[ ‘H] methionyl puromycin 
formed (cpm) 
_ - 507 
_ t 513 
t _ 532 
t t 437 
The mixture (0.2 ml) for the puromycin reaction contained 
50 mM Tris-HCl (pH 7.2), 80 mM NH,Cl, 10 mM Mg ace- 
tate, 1 mM DTT, 1.7 A,,, nm unit of the initiation complex 
containing 8.6 X 10’ cpm of formyl[ “Hlmethionyl-tRNA 
obtained as described in ‘Materials and methods’, and 0.5 mM 
puromycin. Where indicated, 23.6 pg of EF G and 0.2 mM 
GMPPCP were added After incubating for 3 min at 30°C in 
the absence of puromycin, the complete reaction mixture was 
further incubated for 10 min at 30°C. The rest of the proce- 
dure was essentially the same as that of table 1 except that 
10 ml of Triton X-IOO-toluene scintillators were used. 
Another naturally occurring substrate for the 
puromycin reaction is the initiation complex of 
ribosomes. It has been established that formylmethion- 
yl-tRNA [ 171 (like N-acetyl phenylalanyl-tRNA 
[ 181) would bind to 30 S ribosomal subunit at the 
site corresponding to the D site directly. Thus, 
formyl[3H]methionyl-tRNA bound in the presence 
of initiation factors and GTP is placed at the D site 
in a physiological way. As shown in table 5, the reac- 
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tion of this complex with puromycin was insensitive 
to the presence of EF G and GMPPCP. One can there- 
fore conclude from these results that the presence of 
EF G and GTP or GDP on a ribosome which may 
occur temporarily during polypeptide synthesis may 
not interfere with naturally occurring polypeptide 
bond formation. 
4. Discussion 
It has been shown that the puromycin reaction 
with the ribosomal bound formylmethionyl-tRNA is 
inhibited by the presence of IF 2 and GMPPCP on 
ribosomes [ 191. From this observation it has been 
suggested that the terminal phosphate energy of GTP 
is used to release IF 2 from a ribosome. Since it was 
known that EF G and GMPPCP will bind to a riboso- 
me, it was of interest to examine if the binding of 
GMPPCP and EF G to ribosome would exert a similar 
effect as the binding of IF 2 and GMPPCP. The data 
presented in this communication indicate that the 
presence of EF G and GMPPCP on a ribosome may .n(: 
interfere with the puromycin reaction of the D site 
bound N-acetyl [r 4 C] phenylalanyl-tRNA provided 
that the complex was prepared non-enzymatically. The 
inhibition was never complete and it varied from 
30% to 60%. The reason for this incomplete inhibition 
is not known at the present moment. It is possible 
that a part of N-acetyl[’ 4 C] phenylalanyl-tRNA 
bound to the D site in the presence of Mg“ alone may 
be bound in an irregular fashion so that it is suscep- 
tible to the action of EF G and GMPPCP. It should 
be pointed out that under an identical condition, the 
presence of EF G, fusidic acid and GDP on a ribosome 
did not interfere with the puromycin reaction. These 
observations suggest hat the binding site of EF G 
and GMPPCP and that of EF G, fusidic acid and GDP 
on a ribosome may not be identical. It is of interest 
to note the recent report that two molecules of EF G 
bind to a ribosome in the presence of GMPPCP, while 
only one molecule of EF G binds to a ribosome with 
fusidic acid [ 201. The additional molecule of EF G 
on a ribosome may exert steric hindrance to the 
puromycin reaction with the aminoacyl-tRNA which 
is loosely bound to the D site. 
The fact that the observed inhibitory effect of 
EF G and GMPPCP on peptide bond formation does 
Volume 44, number 3 FEBS LETTLRS August 1974 
not operate in physiological protein synthesis was 
suggested by the finding that naturally placed 
N-blocked aminoacyl-tRNA reacted with puromycin 
even in the presence of relatively high concentration 
of EF g and GMPPCP. Although it has been establishe 
that non-enzymatically bound aminoacyl-tRNA is 
physiologically active in that it can form a peptide 
bond [21], the present observation suggest hat at 
least a part of non-enzymatically bound aminoacyl- 
tRNA may not be identical to the naturally placed 
aminoacyl-tRNA on the D site. 
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